Replies to post #242411 on Innovation Pharmaceuticals Inc (IPIX)

[williamssc]

"The Company signed a non-binding term sheet in August 2018 with a global pharmaceutical company for the licensing/rights to Brilacidin for treating oral mucositis and inflammatory bowel diseases. Initial payments, milestone payments and royalties are being negotiated in accordance with the non-binding term sheet".

Proof big money has interest in IPIX.